Clinical Trials

MK-9999-01A/​LIGHTBEAM-U01 - LIGHTBEAM-U01 Substudy 01A: A Phase 1/2 Substudy to Evaluate the Safety and Efficacy of Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors

Link : https://www.clinicaltrials.gov/ct2/show/NCT06395103
Status : span class="RECRUITINGgreen">RECRUITING
Population : 6 Months to 25 Years with Ewing Sarcoma
Description : Zilovertamab Vedotin
PI : C. Vézina
Centers Opened : Montreal Children's Hospital
Phase : I/II
IIST/Pharma : Pharma